Supplementary Figure Legend from Enhanced PI3K P110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a P110α-Selective PI3K Inhibitor

Samuel W. Brady,Jian Zhang,Daniel Seok,Hai Wang,Dihua Yu

DOI: https://doi.org/10.1158/1535-7163.22503321

2023-01-01

Abstract:PDF - 76K, Legends for Supplementary Figures 1-9.

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure 3 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren Averett Byers,Lixia Diao,Jing Wang,Pierre Saintigny,Luc Girard,Michael Peyton,Li Shen,Youhong Fan,Uma Giri,Praveen K. Tumula,Monique B. Nilsson,Jayanthi Gudikote,Hai Tran,Robert J.G. Cardnell,David J. Bearss,Steven L. Warner,Jason M. Foulks,Steven B. Kanner,Varsha Gandhi,Nancy Krett,Steven T. Rosen,Edward S. Kim,Roy S. Herbst,George R. Blumenschein,J. Jack Lee,Scott M. Lippman,K. Kian Ang,Gordon B. Mills,Waun K. Hong,John N. Weinstein,Ignacio I. Wistuba,Kevin R. Coombes,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22446704

2023-01-01

Abstract:PDF file - 66K, CDH1 probes vary in their accuracy and dynamic range
Supplementary Figure 5 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren Averett Byers,Lixia Diao,Jing Wang,Pierre Saintigny,Luc Girard,Michael Peyton,Li Shen,Youhong Fan,Uma Giri,Praveen K. Tumula,Monique B. Nilsson,Jayanthi Gudikote,Hai Tran,Robert J.G. Cardnell,David J. Bearss,Steven L. Warner,Jason M. Foulks,Steven B. Kanner,Varsha Gandhi,Nancy Krett,Steven T. Rosen,Edward S. Kim,Roy S. Herbst,George R. Blumenschein,J. Jack Lee,Scott M. Lippman,K. Kian Ang,Gordon B. Mills,Waun K. Hong,John N. Weinstein,Ignacio I. Wistuba,Kevin R. Coombes,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22446698.v1

2023-01-01

Abstract:PDF file - 50K, Mesenchymal lines are sensitive to Axl inhibition by SGI-7079
Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Xiaohong Wu,Govind Ragupathi,Katherine S. Panageas,Feng Hong,Philip O. Livingston

DOI: https://doi.org/10.1158/1078-0432.22446662

2023-01-01

Abstract:Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Tongxin Liu,Quanquan Sun,Qi Li,Hua Yang,Yuqin Zhang,Rong Wang,Xiaoshan Lin,Dong Xiao,Yawei Yuan,Longhua Chen,Wei Wang

DOI: https://doi.org/10.1158/1535-7163.22502823

2023-01-01

Abstract:Supplementary Figure legends
Supplementary Figure Legend from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

Ninghui Mao,Dong Gao,Wenhuo Hu,Sunyana Gadal,Haley Hieronymus,Shangqian Wang,Young Sun Lee,Patrick Sullivan,Zeda Zhang,Danielle Choi,Neal Rosen,Charles L. Sawyers,Anuradha Gopalan,Yu Chen,Brett S. Carver

DOI: https://doi.org/10.1158/0008-5472.22426324.v1

2023-01-01

Abstract:Figure Legend for supplementary figures
Supplementary Figure Legends from Mir-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma

Jun Wei,Fei Wang,Ling-Yuan Kong,Shuo Xu,Tiffany Doucette,Sherise D. Ferguson,Yuhui Yang,Kayla McEnery,Krishan Jethwa,Olsi Gjyshi,Wei Qiao,Nicholas B. Levine,Frederick F. Lang,Ganesh Rao,Gregory N. Fuller,George A. Calin,Amy B. Heimberger

DOI: https://doi.org/10.1158/0008-5472.22394862.v1

2023-01-01

Abstract:Supplementary Figure Legends - PDF file 70K, Supplementary Figure Legends
Supplementary Figure from Blocking PI3K P110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer

Xueliang Gao,Yubao Wang,Caroline F. Ribeiro,Cherubin Manokaran,Hyeyoun Chang,Thanh Von,Silvia Rodrigues,Onur Cizmecioglu,Shidong Jia,Manav Korpal,Joshua M. Korn,Zhigang Wang,Fabienne Schmit,Lan Jiang,Raymond Pagliarini,Yi Yang,Isha Sethi,Sabina Signoretti,Guo-Cheng Yuan,Massimo Loda,Jean J. Zhao,Thomas M. Roberts

DOI: https://doi.org/10.1158/1541-7786.22527905.v1

2023-01-01

Abstract:Supplementary Figure from Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer
Supplementary Figure and Table Legends from Generating a Murine PTEN Null Cell Line to Discover the Key Role of P110β-Pak1 in Castration-Resistant Prostate Cancer Invasion

Haizhen Wang,Yu Zhou,Chen Chu,Jian Xiao,Shanshan Zheng,Manav Korpal,Joshua M. Korn,Tiffany Penaloza,Richard Drake,Wenjian Gan,Xueliang Gao

DOI: https://doi.org/10.1158/1541-7786.24709994

2023-01-01

Abstract:Supplementary Figure Legends 1-5, Supplementary Table 1
Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu,Monika L. Burness,Rachel Martin-Trevino,Joey Guy,Shoumei Bai,Ramdane Harouaka,Michael Brooks,Shang Li,Alex Fox,Tahra Luther,April Davis,Trenton L. Baker,Justin A. Colacino,Shawn G. Clouthier,Zhi‐Ming Shao,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/1078-0432.22460774.v1

2023-01-01

Abstract:Supplementary figures 1-8 legends
Supplementary Figures S1-S4 from Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Ivan S. Donev,Wei Wang,Tadaaki Yamada,Qi Li,Shinji Takeuchi,Kunio Matsumoto,Takao Yamori,Yasuhiko Nishioka,Saburo Sone,Seiji Yano

DOI: https://doi.org/10.1158/1078-0432.22442205

2023-01-01

Abstract:Supplementary Figures S1-S4.
Supplementary Figure Legends 1- 4 from PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development

Reginald Hill,Joseph Hargan Calvopina,Christine Kim,Ying Wang,David W. Dawson,Timothy R. Donahue,Sarah Dry,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22385235.v1

2023-01-01

Abstract:Supplementary Figure Legends 1- 4 from PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development
Supplementary Figure Legends from DGKA Mediates Resistance to PD-1 Blockade

Lingyi Fu,Sen Li,Weiwei Xiao,Kui Yu,Shuo Li,Sujing Yuan,Jianfei Shen,Xingjun Dong,Ziqian Fang,Jianeng Zhang,Siyu Chen,Wende Li,Hua You,Xiaojun Xia,Tiebang Kang,Jun Tan,Gong Chen,Ankui Yang,Yuanhong Gao,Penghui Zhou

DOI: https://doi.org/10.1158/2326-6066.22543560.v1

2023-01-01

Abstract:Supplementary Figure Legends S1-S6
Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Dalong Cao,Zihao Qi,Yangyang Pang,Haoran Li,Huyang Xie,Junlong Wu,Yongqiang Huang,Yao Zhu,Yijun Shen,Yiping Zhu,Bo Dai,Xin Hu,Dingwei Ye,Ziliang Wang

DOI: https://doi.org/10.1158/0008-5472.22418970

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure Legends from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors

Weicai Chen,Ye Chow Kuang,Haibo Qiu,Zhifa Cao,Yuqing Tu,Quan Z. Sheng,Grant Eilers,He Qian,Hailong Li,Meijun Zhu,Yuexiang Wang,Rongqing Zhang,Yue Wu,Fanyue Meng,Jonathan A. Fletcher,Wen‐Bin Ou

DOI: https://doi.org/10.1158/0008-5472.22414961

2023-01-01

Abstract:This file contains legends for figures supplied as supplementary data. Immunoblot evaluations of EGFR and phospho-EGFR in GIST cell lines and non-small cell lung cancer cell lines (A549 and PC-9). Actin stain is a loading control. Coordinated inhibition of IR and KIT has additive effect on cell viability in imatinib-resistant GIST430, as compared to either intervention alone, but not in imatinib-sensitive GIST882.
Supplementary Figure Legends from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong-Yi Dong,Wen-Zhao Zhong,Xu-Chao Zhang,Jian Su,Zhi Xie,Si-Yang Liu,Hai-Yan Tu,Hua-Jun Chen,Yue-Li Sun,Qing Zhou,Jin-Ji Yang,Xue-Ning Yang,Jia-Xin Lin,Hong-Hong Yan,Hao-Ran Zhai,Li-Xu Yan,Ri-Qiang Liao,Si-Pei Wu,Yi-Long Wu

DOI: https://doi.org/10.1158/1078-0432.22462077.v1

2023-01-01

Abstract:Supplementary Figure legends
Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Ying Zhou,Jason Dang,Kung-Yen Chang,Edwin Yau,Pedro Aza-Blanc,Jorge Moscat,Tariq M. Rana

DOI: https://doi.org/10.1158/0008-5472.22409370.v1

2023-01-01

Abstract:Legend for Supplementary Figures S1-S8
Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387137.v1

2023-01-01

Abstract:Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Yifan Wang,Nan Li,Jinyu Wen,Weiye Deng,Rui Ye,Xu Cai,Yawei Qiao,Amrish Sharma,Ming Zhang,Mien‐Chie Hung,Steven H. Lin

DOI: https://doi.org/10.1158/1078-0432.22469730.v1

2023-01-01

Abstract:Supplementary figure legends

Supplementary Figure Legend from Enhanced PI3K P110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a P110α-Selective PI3K Inhibitor

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure 3 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Supplementary Figure 5 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Supplementary Figure Legend from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

Supplementary Figure Legends from Mir-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma

Supplementary Figure from Blocking PI3K P110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer

Supplementary Figure and Table Legends from Generating a Murine PTEN Null Cell Line to Discover the Key Role of P110β-Pak1 in Castration-Resistant Prostate Cancer Invasion

Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Supplementary Figures S1-S4 from Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Supplementary Figure Legends 1- 4 from PTEN Loss Accelerates &lt;i&gt;Kras&lt;/i&gt;&lt;sup&gt;&lt;i&gt;G12D&lt;/i&gt;&lt;/sup&gt;-Induced Pancreatic Cancer Development

Supplementary Figure Legends from DGKA Mediates Resistance to PD-1 Blockade

Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Supplementary Figure Legends from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors

Supplementary Figure Legends from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Supplementary Figure Legends 1- 4 from PTEN Loss Accelerates <i>Kras</i><sup><i>G12D</i></sup>-Induced Pancreatic Cancer Development